Sharp Biomedical Raises Pre-Seed Funding Led by Gener8tor

Who founded Sharp Biomedical?

Sharp Biomedical was founded in 2024 by Dan Newman. The company focuses on developing medical toolset's and implants for spinal care with an emphasis on manual procedures that can be performed in outpatient facilities.

"While the industry is rightfully focused on remarkable advancements in robotics and complex technologies for late-stage spinal care, we see a massive unmet need earlier in the care continuum," said Dan Newman, Founder and CEO of Sharp Biomedical. "We are thrilled to partner with gener8tor 1889 and our angel investors to finalize our development

"Dan is an extremely impressive startup founder, and we have built a huge amount of conviction in him and the entire Sharp Biomedical team," said Ben Stanley, Principal of gener8tor 1889. "Their mission to democratize access to spine care by empowering outpatient clinics with fast, safe, and reliable toolsets is a breath of fresh air in a highly complex industry.

Market and Business Growth

Sharp Biomedical is developing its technology for outpatient pain clinics that treat patients with early-to-mid-stage chronic pain.

The company’s approach aims to reduce dependence on large hospital infrastructure and complex equipment. No revenue, customer, clinical testing or commercial deployment figures have been disclosed.

What Happens Next?

Sharp Biomedical plans to continue developing and testing its first device system, incorporating physician input and working toward its next regulatory milestones. The company’s longer-term goal is to bring its flagship device to market for use in outpatient pain clinics.

Read More:HCLTech Announces Global Premier Partnership with Anthropic